1. Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study. Issue 1 (20th January 2018) Authors: Strongman, Helen; Christopher, Solomon; Majak, Maila; Williams, Rachael; Bahmanyar, Shahram; Linder, Marie; Heintjes, Edith M; Bennett, Dimitri; Korhonen, Pasi; Hoti, Fabian Journal: BMJ open diabetes research and care Issue: Volume 6:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study. Issue 1 (29th May 2017) Authors: Strongman, Helen; Korhonen, Pasi; Williams, Rachael; Bahmanyar, Shahram; Hoti, Fabian; Christopher, Solomon; Majak, Maila; Kool-Houweling, Leanne; Linder, Marie; Dolin, Paul; Heintjes, Edith M Journal: BMJ open diabetes research and care Issue: Volume 5:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries. (16th August 2016) Authors: Korhonen, Pasi; Heintjes, Edith M; Williams, Rachael; Hoti, Fabian; Christopher, Solomon; Majak, Maila; Kool-Houweling, Leanne; Strongman, Helen; Linder, Marie; Dolin, Paul; Bahmanyar, Shahram Journal: BMJ Issue: Volume 354(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗